Page last updated: 2024-11-03

praziquantel and Mast Cell Activation Disease

praziquantel has been researched along with Mast Cell Activation Disease in 2 studies

azinox: Russian drug

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hrckova, G1
Velebný, S1
Daxnerová, Z1
Solár, P1
Starke, WA1
Oaks, JA1

Other Studies

2 other studies available for praziquantel and Mast Cell Activation Disease

ArticleYear
Praziquantel and liposomized glucan-treatment modulated liver fibrogenesis and mastocytosis in mice infected with Mesocestoides vogae (M. corti, Cestoda) tetrathyridia.
    Parasitology, 2006, Volume: 132, Issue:Pt 4

    Topics: Animals; Anthelmintics; beta-Glucans; Bromodeoxyuridine; Cestode Infections; Collagen; Drug Therapy,

2006
Hymenolepis diminuta: praziquantel removal of adult tapeworms is followed by apoptotic down-regulation of mucosal mastocytosis.
    Experimental parasitology, 1999, Volume: 92, Issue:3

    Topics: Animals; Antiplatyhelmintic Agents; Apoptosis; Down-Regulation; Hymenolepiasis; Hymenolepis; Ileum;

1999